CSC
SLS icon

Caldwell Sutter Capital’s SELLAS Life Sciences SLS Stock Holding History

Caldwell Sutter Capital’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48K Hold
100
– – ﹤0.01% 830
2026
Q1 		$423 Hold
100
– – ﹤0.01% 853
2025
Q4 		$377 Hold
100
– – ﹤0.01% 839
2025
Q3 		$161 Hold
100
– – ﹤0.01% 846
2025
Q2 		$219 Hold
100
– – ﹤0.01% 823
2025
Q1 		$108 Buy
+100
New +$119 ﹤0.01% 866

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Caldwell Sutter Capital's SLS Position: Q2 2026 in Review

Caldwell Sutter Capital held its SELLAS Life Sciences (SLS) position steady in Q2 2026 at 100 shares worth $1.48K. The position accounts for ﹤0.01% of the portfolio, ranked #830.

Caldwell Sutter Capital first reported a position in SLS in Q1 2025 and has held it in 6 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Caldwell Sutter Capital held 100 shares of SELLAS Life Sciences worth $1.48K as of Q2 2026.
  • Caldwell Sutter Capital left its SELLAS Life Sciences share count unchanged in Q2 2026.
  • SELLAS Life Sciences made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q2 2026, its #830 holding.
  • Caldwell Sutter Capital first reported a position in SELLAS Life Sciences in Q1 2025 and has held it in 6 quarters since.
  • 192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.